Barton F. Haynes

Duke University

NIH Rank #48
  • Top 1% Funded
  • Early Career

NIH Funding · FY2024

Total Funding
$36.9M
Fiscal year 2024
Grants Awarded
7
Active NIH grants
National Rank
#48
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $36.9M across 7 grants · National rank #48.

Top grants by award amount

Barton F. Haynes's NIH grant portfolio, ranked by award amount.

  • 5UM1AI144371-06UM1
    Induction of protective antibodies for HIV vaccine development
    $21M
    award amount
  • 3UM1AI144371-06S5UM1
    Manufacture a protein encoding CAP256.wk34.c80 OPT4 envelope for induction of V2 Apex bnAbs
    $5.3M
    award amount
  • 3UM1AI144371-06S4UM1
    Manufacture an mRNA/LNP encoding an HIV envelope designed to bind and stimulate multiple V2 Apex broadly neutralizing antibody B cell lineages
    $3.2M
    award amount
  • 3UM1AI144371-06S1UM1
    Nonhuman primate studies for development of a prototype HIV vaccine that induces broadly neutralizing antibodies
    $3.2M
    award amount
  • 3UM1AI144371-06S3UM1
    Immunologic evaluation of HIV-1 HVTN experimental medicine trials HVTN 307, HVTN 309 and HVTN312
    $2.7M
    award amount
  • 3UM1AI144371-06S2UM1
    HIV-1 Env immunogens that target unmutated common ancestor antibodies (UCAs) of broadly neutralizing antibodies (bnAbs) reactive with multiple HIV-1 envelope epitopes
    $809.7K
    award amount
  • 5U19AI142596-05U19
    Messenger RNA Immunogens for initiation of protective HIV non-neutralizing antibodies
    $677.6K
    award amount

Affiliation

Institutions that have administered grants for Barton F. Haynes.

Affiliated with Duke University (NC).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Duke University
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    $5M Cumulative Funding
  6. 2024
    $10M Cumulative Funding
  7. 2024
    $25M Cumulative Funding
  8. 2024
    Entered Top 50% Nationally
    Ranked #48
  9. 2024
    Entered Top 25% Nationally
    Ranked #48
  10. 2024
    Entered Top 10% Nationally
    Ranked #48
  11. 2024
    Entered Top 5% Nationally
    Ranked #48
  12. 2024
    Entered Top 1% Nationally
    Ranked #48